Literature DB >> 10360829

Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells.

E T Walch1, A P Albino, D Marchetti.   

Abstract

The role of growth factor receptors in regulating the progression of human melanocytes toward tumorigenicity and ultimately a malignant phenotype is poorly understood. In particular, the autocrine and paracrine influences that modulate cellular invasion and extracellular matrix (ECM)-degradative enzymes in melanoma cells remain undefined at the molecular level. The low-affinity p75 neurotrophin receptor (p75NTR), a cysteine-rich transmembrane glycoprotein, is frequently expressed in advanced stages of human melanoma, but the biological consequences of this expression are unknown. p75NTR can enhance the invasive potential of brain-metastatic melanoma cells in vitro. We have extended here these results and related the level of p75NTR in human metastatic melanoma cells to their invasive potential to target organs other than brain. Fluorescence activated cell sorting (FACS) analysis showed that 3 melanoma cell lines (SK-MEL-146, SK-MEL-119, 70W) had differential p75NTR contents, whereas SK-MEL-147 cells had elevated amounts of p75NTR. Two other melanoma cell lines (SK-MEL-94, SK-MEL-110) with point mutations in the p75NTR transmembrane domain had reduced (SK-MEL-94) or absent (SK-MEL-110) p75NTR. We also examined these cell lines for presence of TrkA receptor, the high-affinity receptor for nerve growth factor (NGF), the prototypic neurotrophin. No TrkA receptor expression was detected in any of the cell lines. The extent of p75NTR expression correlated with the capability of NGF to promote cellular invasion and with production of heparanase, an important ECM-degradative enzyme. Melanoma cells sorted for high p75NTR expression (p75NTR-H cells) had markedly greater (9- to 13-fold increase) invasive capabilities in response to NGF exposure than those sorted for low p75NTR expression (p75NTR-L cells). Additionally, NGF induced a 8- to 10-fold increase of heparanase activity in p75NTR-H cells. Thus, we propose that p75NTR-mediated trophic support profoundly affects melanoma cell invasion to neurotrophin-rich organs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360829     DOI: 10.1002/(sici)1097-0215(19990702)82:1<112::aid-ijc19>3.0.co;2-9

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair.

Authors:  Christian Schachtrup; Natacha Le Moan; Melissa A Passino; Katerina Akassoglou
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

2.  Neurotrophins in healthy and diseased skin.

Authors:  Francesca Truzzi; Alessandra Marconi; Carlo Pincelli
Journal:  Dermatoendocrinol       Date:  2011-01

3.  Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma.

Authors:  Ben Davidson; Lina Vintman; Eyal Zcharia; Carlos Bedrossian; Aasmund Berner; Søren Nielsen; Neta Ilan; Israel Vlodavsky; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 4.  Brain metastases in melanoma: roles of neurotrophins.

Authors:  Yvonne Denkins; Jane Reiland; Madhuchhanda Roy; Neeta D Sinnappah-Kang; Jennifer Galjour; Brian P Murry; Jason Blust; Rebecca Aucoin; Dario Marchetti
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

5.  Current concepts of metastasis in melanoma.

Authors:  Blazej Zbytek; J Andrew Carlson; Jacqueline Granese; Jeffrey Ross; Martin C Mihm; Andrzej Slominski
Journal:  Expert Rev Dermatol       Date:  2008-10

Review 6.  Brain-metastatic melanoma: a neurotrophic perspective.

Authors:  Dario Marchetti; Yvonne Denkins; Jane Reiland; Andrea Greiter-Wilke; Jennifer Galjour; Brian Murry; Jason Blust; Madhuchhanda Roy
Journal:  Pathol Oncol Res       Date:  2003-10-07       Impact factor: 3.201

7.  Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma.

Authors:  Y H Liao; S M Hsu; H L Yang; M S Tsai; P H Huang
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

8.  Expression of NGF/proNGF and Their Receptors TrkA, p75NTR and Sortilin in Melanoma.

Authors:  Mark Marsland; Amiee Dowdell; Chen Chen Jiang; James S Wilmott; Richard A Scolyer; Xu Dong Zhang; Hubert Hondermarck; Sam Faulkner
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

9.  The p75 neurotrophin receptor is a central regulator of glioma invasion.

Authors:  Angela L M Johnston; Xueqing Lun; Jennifer J Rahn; Abdelhamid Liacini; Limei Wang; Mark G Hamilton; Ian F Parney; Barbara L Hempstead; Stephen M Robbins; Peter A Forsyth; Donna L Senger
Journal:  PLoS Biol       Date:  2007-08       Impact factor: 8.029

10.  TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines.

Authors:  Luigi Pasini; Angela Re; Toma Tebaldi; Gianluca Ricci; Sebastiana Boi; Valentina Adami; Mattia Barbareschi; Alessandro Quattrone
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.